After 10 years of innovation in transrectal biopsy, KOELIS improves current practices of transperineal biopsies
KOELIS has helped physicians to perform transrectal prostate biopsies since 2006. Ten years later, more than 150,000 patients have benefited from KOELIS technology and 170 systems have been installed around the world. Featured in more than 50 scientific publications, KOELIS has become a key figure in the diagnosis of prostate cancer. KOELIS offers now a break-through transperineal approach in prostate interventions with a new 3D side-fire ultrasound probe, exclusive guides and a dedicated software application.